CVE:MFS Medifocus Inc. (MFS.V) (MFS) Stock Price, News & Analysis → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free MFS Stock Alerts C$0.01 0.00 (0.00%) (As of 09/4/2020) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.02Volume26,000 shsAverage Volume317,764 shsMarket CapitalizationC$1.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Medifocus Inc. (MFS.V) alerts: Email Address Ad Unstoppable ProsperityDividend-like income from non-dividend stocksThis coming Wednesday @ 7 PM EST you're going to discover… How to find safe value in the stocks you already own with simple Cash Flow Trade Strategies.Click here to register for free. About Medifocus Inc. (MFS.V) Stock (CVE:MFS)Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.Read More MFS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MFS Stock News HeadlinesMarch 21, 2024 | ca.finance.yahoo.comInsuraGuest Technologies Inc. (ISGI.V)February 18, 2024 | ca.finance.yahoo.comVior Inc. (VIO.V)December 30, 2023 | ca.finance.yahoo.comBeacn Wizardry and Magic Inc. (BECN.V)December 12, 2023 | ca.finance.yahoo.comKidoz Inc. (KIDZ.V)December 4, 2023 | ca.finance.yahoo.comCO2 Gro Inc. (GROW.V)December 1, 2023 | morningstar.comVisa Inc Class AOctober 31, 2023 | morningstar.comVisa Inc Class A VAugust 9, 2023 | ca.finance.yahoo.comG2 Goldfields Inc. (GTWO.V)June 9, 2023 | ca.finance.yahoo.comRHT.V - Reliq Health Technologies Inc.May 30, 2023 | ca.finance.yahoo.comALDE.V - Aldebaran Resources Inc.May 30, 2023 | finance.yahoo.comWWT.V - Water Ways Technologies Inc.May 17, 2023 | ca.finance.yahoo.comTrustBIX Inc. (TBIX.V)April 28, 2023 | benzinga.comMfs Intermediate High Inc Stock (NYSE:CIF), Short Interest ReportApril 12, 2023 | ca.finance.yahoo.comZedcor Inc. (ZDC.V)April 11, 2023 | morningstar.comMFS Lifetime 2030 R6April 9, 2023 | morningstar.comMFS Lifetime 2030 CApril 6, 2023 | morningstar.comMFS Lifetime 2045 AMarch 28, 2023 | morningstar.comMFS Lifetime 2040 R6March 24, 2023 | morningstar.comMFS Lifetime 2025 R4March 21, 2023 | morningstar.comMFS Lifetime 2030 AMarch 12, 2023 | morningstar.comMFS Lifetime 2025 AMarch 12, 2023 | morningstar.comMFS Lifetime 2045 IMarch 11, 2023 | morningstar.comMFS Lifetime 2035 R4March 2, 2023 | morningstar.comMFS Lifetime 2040 AMarch 1, 2023 | morningstar.comMFS Lifetime 2030 R4See More Headlines Receive MFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifocus Inc. (MFS.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:MFS CUSIPN/A CIKN/A Webwww.medifocusinc.com Phone+1-905-3197070FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.03 Sales & Book Value Annual SalesC$2.23 million Price / Sales0.83 Cash FlowC$0.00 per share Price / Cash Flow10.00 Book ValueC($0.07) per share Price / Book-0.15Miscellaneous Outstanding Shares184,984,000Free FloatN/AMarket CapC$1.85 million OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. William W. Jow (Age 63)CEO, Pres & Medical Director Comp: $180kMr. Charkes C. Shelton (Age 75)Exec. VP and Gen. Counsel Key CompetitorsPacgen Life Science Co. (PBS.V)CVE:PBSSolarvest BioEnergyCVE:SVSPascal BiosciencesCVE:PASiCo TherapeuticsCVE:ICOCotinga Pharmaceuticals Inc. (COT.V)CVE:COTView All Competitors MFS Stock Analysis - Frequently Asked Questions How have MFS shares performed in 2024? Medifocus Inc. (MFS.V)'s stock was trading at C$0.01 at the beginning of the year. Since then, MFS stock has increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. What other stocks do shareholders of Medifocus Inc. (MFS.V) own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medifocus Inc. (MFS.V) investors own include (RLYP) (RLYP), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE), Chevron (CVX), BP Prudhoe Bay Royalty Trust (BPT) and How do I buy shares of Medifocus Inc. (MFS.V)? Shares of MFS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:MFS) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersBitcoin’s Biggest Year YetParadigm PressDividend-like income from non-dividend stocksUnstoppable ProsperityWrite this ticker symbol down…StocksToTradeThis could mean the end of the U.S dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersGold Set to EXPLODE!Gold Safe Exchange[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifocus Inc. (MFS.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.